A rising number of people have accepted GLP-1s as a way to treat obesity, which affects more than 100 million Americans.

Colorado plans to limit insurance coverage for weight-loss drugs like Wegovy and Ozempic for thousands of state employees.

Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will be subject to the next round of Medicare price negotiations, the Biden ...

The U.S. Centers for Medicare and Medicaid Services has named Novo Nordisk’s Wegovy, Ozempic and Rybelsus as part of the ...

Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

An observational analysis finds the drugs may lower the risk of substance abuse and cognitive issues. But the findings need ...

Surgical patients may still have leftovers in their system even after a standard fast, potentially increasing the chance of a ...

Semaglutide, sold under the brand names of Ozempic, Rybelsus and Wegovy, is one of the most popular drugs on the market.

These compounds take a different approach to weight loss than existing medications, which can cause nausea, vomiting and ...

The move could mean savings for consumers. Weight loss drugs Ozempic and Wegovy have been added to the list of medications Medicare will be able to negotiate directly with drug manufacturers ...

A study confirmed that side effects like pancreatitis and kidney damage are possible while taking GLP-1s like Ozempic. Here's ...

The use of injectable weight loss medications like Wegovy and Ozempic, both produced by Danish manufacturer Novo Nordisk, has grown massively in recent years, since the two drugs were approved for ...